M&A Advisor’s 2011 Magnus Award for Deal of the Year

Pfizer Inc.’s acquisition of King Pharmaceuticals, for which Cadwalader served as counsel to Pfizer, was nominated for the M&A Advisor’s Magnus Award for Deal of the Year.

CadwaladerSpotlight

April 19: Trading Risk's London ILS Conference 2018

Robert Cannon will discuss the U.K.’s new insurance-linked securities framework.

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.